Clinical Trials
3 articles

Biotech & Healthtech
How AI is Revolutionizing Drug Discovery and Treatment
AI-discovered molecules are achieving an 80-90% success rate in Phase I clinical trials, dramatically outperforming traditional methods and signaling a new era for drug development.
Mateo Rossi·September 4, 2026

Biotech & Healthtech
AI in early drug discovery: Advantages and challenges
AI-discovered molecules have an 80-90% success rate in Phase I clinical trials, a figure substantially higher than historic industry averages, according to PubMed and Nature .
Mateo Rossi·July 19, 2026

Biotech & Healthtech
What is CRISPR Gene Editing and Why is it Revolutionizing Medicine?
In 2020, a CRISPR treatment was injected directly into human patients for the first time, marking a pivotal moment in the quest to rewrite the human genome.
Mateo Rossi·June 19, 2026
